Menu ×

HEALTHCARE & PHARMACEUTICAL

Auto-Injector Market Segmentation by Type (Disposable Auto-Injector, and Reusable Auto-Injector); by Route of Administration (Subcutaneous, and Intramuscular); by Drug Type (Epinephrine, Insulin, Rebif ); by Application (Rheumatoid Arthritis, Anaphylaxis, Diabetes, Multiple Sclerosis, Psoriasis, and Others); by Demography (Pediatric, Adults, & Geriatric); by Distribution Channel (Hospital, Retail, & Online Pharmacies); and by End-User – Global Demand Analysis & Opportunity Outlook 2020-2030

  • Text Size:

Extensive insights into the Growth of Auto-Injector Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More

IN THE NEWS

  • November 19, 2019: Antares Pharma, Inc. announced that it has entered into a global development agreement with Idorsia Pharmaceuticals Ltd. for developing a novel drug-device product that would combine Idorsia’s P2Y12 receptor antagonist, selatogrel, with the subcutaneous auto injector of Antares, QuickShot.

Global Auto-Injector Market Highlights Over 2020 - 2030

The global auto-injector market is estimated to garner a revenue of USD 11354.6 Million by the end of 2030, by growing at a CAGR of 13.9% over the forecast period, i.e., 2021 – 2030. Further, in the year 2020, the market garnered a revenue of USD 3117.4 Million. The growth of the market can primarily be attributed to the increasing prevalence of allergies worldwide, such as anaphylaxis, along with the increasing cases of diabetes, which is driving the need for auto-injectors for injecting drugs to treat these diseases. According to the statistics by the Asthma and Allergy Foundation of America (AAFA), in the United States, allergic conditions are one of the most common health issues that affects both adult and children. It also stated that every year, it had been estimated that anaphylaxis to food resulted in 30,000 emergency room visits. On the other hand, according to the statistics by the International Diabetes Foundation (IDF), by the end of 2045, adults living with diabetes is expected to touch 700 Million.

Auto-Injector Market Graph

Anaphylaxis, which is a severe and sometimes a sudden allergic reaction, is life-threatening and requires immediate emergency response. The patients, who are at risk for anaphylaxis, are commonly prescribed epinephrine auto injector (EAI), which is known to be an effective solution for the management of the disease. On the other hand, people suffering from diabetes, are required to inject insulin almost on a daily basis, which is anticipated to drive the need for auto-injectors. Such factors are projected to drive the growth of the global auto-injectors market during the forecast period. CLICK TO DOWNLOAD SAMPLE REPORT

Global Auto-Injector Market Regional Synopsis

Regionally, the global auto-injector market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America region is anticipated to garner the largest market revenue of USD 4404.5 Million by the end of 2030, and further hold the highest market share during the forecast period. The growth of the market in the region can primarily be attributed to the increasing awareness for allergic and diabetes diseases, which is driving the need for auto-injectors. According to the statistics by the Allergy & Asthma Network, between 1.6% and 5.1% of the population of the United States have experiences anaphylaxis. The market in the region is segmented by country into the United States and Canada. Out of the market in these countries, the market in the United States is projected to hold the highest market share during the forecast period, while the market in Canada is anticipated to grow with the highest CAGR of 14.2% during the forecast period.

The auto-injectors market in Europe is anticipated to hold the second-leading market share during the forecast period and further attain a revenue of USD 4008.2 Million by the end of 2030, up from USD 1084.2 Million in 2020. The market in the region is segmented by country into the United Kingdom, Germany, Italy, France, Spain, Russia, Netherlands, and the Rest of Europe. Out of the market in these countries, the market in Germany is projected to attain the largest revenue of USD 846.1 Million by the end of 2030, and is further anticipated to grow with a CAGR of 14.3% during the forecast period.

The study further incorporates Y-O-Y Growth, market opportunities, demand & supply and forecast future opportunity in North America (United States, Canada, Mexico), South America, Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).

Growth Drivers and Challenges Impacting the Growth of the Global Auto-Injector Market

Growth Drivers

  • Increasing Prevalence of Anaphylaxis
  • Growing Demand for Auto-Injectors Amongst Diabetic Patients

Challenges

  • Availability of Low-Cost Alternatives
  • High Price of the Injecting Device

Global Auto-Injector Market Segmentation Synopsis

The global auto-injector market is segmented by type into disposable auto-injector, and reusable auto-injector, out of which, the disposable auto-injector segment is projected to garner the highest market share by the end of 2030 and also grow with the highest CAGR of 14% during the forecast period. Further, on the basis of route of administration, the market is segmented into subcutaneous, and intramuscular, out of which, the subcutaneous segment is projected to grow with the highest CAGR of 14.1% during the forecast period. By drug type, the market is segmented into epinephrine, insulin, Rebif, and others. Out of these, the epinephrine segment registered the largest revenue of USD 857.2 Million in the year 2020, and is further expected to touch USD 3230.8 Million by the end of 2030. The global auto-injector market is further segmented on the basis of application into rheumatoid arthritis, anaphylaxis, diabetes, multiple sclerosis, psoriasis, and others, out of which, the diabetes segment is projected to grow with the highest CAGR of 17.5% during the forecast period. On the basis of demography, the market is segmented into pediatric, adults, and geriatric, out of which, the geriatric segment is anticipated to attain the largest revenue of USD 5368.6 Million by the end of 2030 and grow with the highest CAGR of 14.7% during the forecast period. Further, on the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Amongst these segments, the retail pharmacies segment is projected to register the largest revenue of USD 5865.8 Million by the end of 2030. By end-user, the market is segmented into hospital & clinics, home care settings, and ambulatory surgical centers, out of which, the home care settings segment is projected to grow with the highest CAGR of 14.2% during the forecast period and further attain the largest revenue of USD 7496.3 Million by the end of 2030.

Key Companies Dominating the Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global auto-injector market that are included in our report are Pfizer Inc., BD, Adamis Pharmaceuticals Corporation, Biogen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Antares Pharma, Inc., Sanofi S.A., Ypsomed AG, SHL Medical AG, and others.

Key Reasons to Buy Our Report

  • The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
  • It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
  • The report includes detailed company profiles of the major players dominating the market.
  • We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
  • We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.

FREQUENTLY ASKED QUESTIONS

  1. Market Definition
    1. Market Definition
    2. Market Segmentation
  2. Assumptions and Acronyms
  3. Research Methodology
    1. Research Process
    2. Primary Research
    3. Secondary Research
    4. Market Size Estimation
  4. Executive Summary – Global Auto-Injector Market
  5. Industry Value Chain Analysis
    1. Manufacturers
    2. Distributors
    3. End-Users
  6. Market Dynamics
    1. Market Drivers
    2. Market Restraint
    3. Market Opportunity
    4. Market Trends
  7. Regulatory and Standards Landscape
  8. Industry Risk Analysis
  9. Impact of COVID-19 on the Global Auto-Injector Market (2020-2029)
    1. Impact on the Demand
    2. Impact on Auto-Injectors Providers
    3. Impact on Strategy
    4. Impact on the Manufacturers
    5. Impact on Spending of End-Users
    6. Impact on New Market Trends
  10. Recent Developments in the Auto-Injector Market
  11. Comparative Analysis on the Type of Auto-Injectors
  12. Analysis on the Errors
  13. Comparative Analysis
  14. Competitive Landscape
    1. Market Share Analysis, 2020
    2. Company Profiles
      1. Pfizer Inc.
      2. BD
      3. Adamis Pharmaceuticals Corporation
      4. Biogen Inc.
      5. Teva Pharmaceutical Industries Ltd.
      6. Mylan N.V.
      7. Antares Pharma, Inc.
      8. Sanofi S.A.
      9. Ypsomed AG
      10. SHL Medical AG
  15. Global Auto-Injector Market 2020-2030
    1. Market Overview
    2. By Value (USD Million)
  16. Global Auto-Injector Market-Segmentation Analysis 2020-2030
    1. By Type
      1. Disposable Auto-Injector, 2020-2030F (USD Million)
      2. Reusable Auto-Injector, 2020-2030F (USD Million)
    2. By Route of Administration
      1. Subcutaneous, 2020-2030F (USD Million)
      2. Intramuscular, 2020-2030F (USD Million)
    3. By Drug Type
      1. Epinephrine, 2020-2030F (USD Million)
      2. Insulin, 2020-2030F (USD Million)
      3. Rebif, 2020-2030F (USD Million)
      4. Others, 2020-2030F (USD Million)
    4. By Application
      1. Rheumatoid Arthritis, 2020-2030F (USD Million)
      2. Anaphylaxis, 2020-2030F (USD Million)
      3. Diabetes, 2020-2030F (USD Million)
      4. Multiple Sclerosis, 2020-2030F (USD Million)
      5. Psoriasis, 2020-2030F (USD Million)
      6. Others, 2020-2030F (USD Million)
    5. By Demography
      1. Pediatric, 2020-2030F (USD Million)
        1. Neonates, 2020-2030F (USD Million)
        2. Infants, 2020-2030F (USD Million)
        3. Children, 2020-2030F (USD Million)
        4. Adolescents, 2020-2030F (USD Million)
      2. Adults, 2020-2030F (USD Million)
      3. Geriatric, 2020-2030F (USD Million)
    6. By Distribution Channel
      1. Hospital Pharmacies, 2020-2030F (USD Million)
      2. Retail Pharmacies, 2020-2030F (USD Million)
      3. Online Pharmacies, 2020-2030F (USD Million)
    7. By End-User
      1. Hospital & Clinics, 2020-2030F (USD Million)
      2. Home Care Settings, 2020-2030F (USD Million)
      3. Ambulatory Surgical Centers, 2020-2030F (USD Million)
    8. By Region
      1. North America
      2. Europe
      3. Latin America
      4. Asia Pacific
      5. Middle East & Africa
  17. North America Auto-Injector Market
    1. Market Overview
    2. Market Value (USD Million)
    3. Market Segmentation by:
    4. By Type
      1. Disposable Auto-Injector, 2020-2030F (USD Million)
      2. Reusable Auto-Injector, 2020-2030F (USD Million)
    5. By Route of Administration
      1. Subcutaneous, 2020-2030F (USD Million)
      2. Intramuscular, 2020-2030F (USD Million)
    6. By Drug Type
      1. Epinephrine, 2020-2030F (USD Million)
      2. Insulin, 2020-2030F (USD Million)
      3. Rebif, 2020-2030F (USD Million)
      4. Others, 2020-2030F (USD Million)
    7. By Application
      1. Rheumatoid Arthritis, 2020-2030F (USD Million)
      2. Anaphylaxis, 2020-2030F (USD Million)
      3. Diabetes, 2020-2030F (USD Million)
      4. Multiple Sclerosis, 2020-2030F (USD Million)
      5. Psoriasis, 2020-2030F (USD Million)
      6. Others, 2020-2030F (USD Million)
    8. By Demography
      1. Pediatric, 2020-2030F (USD Million)
        1. Neonates, 2020-2030F (USD Million)
        2. Infants, 2020-2030F (USD Million)
        3. Children, 2020-2030F (USD Million)
        4. Adolescents, 2020-2030F (USD Million)
      2. Adults, 2020-2030F (USD Million)
      3. Geriatric, 2020-2030F (USD Million)
    9. By Distribution Channel
      1. Hospital Pharmacies, 2020-2030F (USD Million)
      2. Retail Pharmacies, 2020-2030F (USD Million)
      3. Online Pharmacies, 2020-2030F (USD Million)
    10. By End-User
      1. Hospital & Clinics, 2020-2030F (USD Million)
      2. Home Care Settings, 2020-2030F (USD Million)
      3. Ambulatory Surgical Centers, 2020-2030F (USD Million)
    11. By Country
  18. Europe Auto-Injector Market
    1. Market Overview
    2. Market Value (USD Million)
    3. Market Segmentation by:
    4. By Type
    5. By Route of Administration
    6. By Drug Type
    7. By Application
    8. By Demography
    9. By Distribution Channel
    10. By End-User
    11. By Country
  19. Latin America Auto-Injector Market
    1. Market Overview
    2. Market Value (USD Million)
    3. Market Segmentation by:
    4. By Type
    5. By Route of Administration
    6. By Drug Type
    7. By Application
    8. By Demography
    9. By Distribution Channel
    10. By End-User
    11. By Country
  20. Asia Pacific Auto-Injector Market
    1. Market Overview
    2. Market Value (USD Million)
    3. Market Segmentation by:
    4. By Type
    5. By Route of Administration
    6. By Drug Type
    7. By Application
    8. By Demography
    9. By Distribution Channel
    10. By End-User
    11. By Country
  21. Middle East & Africa Auto-Injector Market
    1. Market Overview
    2. Market Value (USD Million)
    3. Market Segmentation by:
    4. By Type
    5. By Route of Administration
    6. By Drug Type
    7. By Application
    8. By Demography
    9. By Distribution Channel
    10. By End-User
    11. By Country

Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved